新OPTN/UNOS数据显示接受ECMO支持的肺移植候选者等待名单死亡率高于既往报告
研究基于美国移植受者科学登记系统2016年5月1日至2020年6月1日成人肺移植候选者数据,分析ECMO作为时间依赖变量的等待名单结局及移植后生存。867例移植前使用ECMO,其中247例经新数据源识别;ECMO候选者因病情过重或死亡被移出等待名单的校正风险增加23.9倍,移植校正风险仅增加4.08倍;移植后静脉-动脉和静脉-静脉ECMO配置的死亡风险比分别为1.67和1.45。
要点
- 新数据源额外识别28.5%的ECMO桥接肺移植候选者。
- ECMO候选者因病情过重或死亡被移出等待名单的校正风险增加23.9倍。
- ECMO桥接移植后静脉-动脉和静脉-静脉配置的死亡风险比分别为1.67和1.45。
核心结论
- 新数据识别出额外28.5%的ECMO桥接肺移植候选者,完整队列显示ECMO使用率更高且等待名单死亡风险因素被低估,应据此制定策略以及时为该人群提供移植机会。
研究设计与样本
- 研究纳入2016年5月1日至2020年6月1日美国成人肺移植候选者,数据来自美国移植受者科学登记系统多个来源。
- 等待名单分析采用累积发生率函数和Cox比例风险模型,将ECMO作为时间依赖变量。
- 移植后分析采用Kaplan-Meier法、Cox比例风险模型和观察与预期生存比。
主要发现
- 共有867例候选者在移植前使用ECMO,其中247例通过新数据源识别。
- ECMO候选者因病情过重或死亡被移出等待名单的校正似然增加23.9倍,移植校正似然仅增加4.08倍。
- ECMO桥接后接受肺移植的候选者(N=587)移植后总死亡风险增加,静脉-动脉和静脉-静脉配置的风险比分别为HR=1.67(95%CI,1.16,2.40)和HR=1.45(95%CI,1.15,1.82)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of extracorporeal membrane oxygenation (ECMO) is not currently incorporated into US allocation models due to the historical lack of complete data in the national US registry which changed in 2016 to include ECMO at the time of waitlist removal and more granular timing and configuration data. METHODS: We studied adult lung transplant candidates from May 1, 2016 to June 1, 2020 with data abstracted from multiple sources in the US Scientific Registry of Transplant Recipients. Waitlist analyses included cumulative incidence functions and Cox proportional hazards models considering ECMO as a time-dependent variable. Post-transplant analyses included Kaplan Meier, Cox proportional hazards models, and observed to expected survival ratios. RESULTS: A total of 867 candidates were on ECMO prior to transplant; 247 were identified using new sources of data. Candidates on ECMO had a 23.9 increased adjusted likelihood of waitlist removal for being too sick or death, but only a 4.08 increased adjusted likelihood of transplant. Candidates bridged with ECMO who underwent lung transplant (N = 587) experienced an increased overall hazard of post-transplant mortality with veno-arterial and veno-venous configurations conferring hazard ratio (HR) = 1.67 (95% CI, 1.16, 2.40), HR = 1.45 (95% CI, 1.15, 1.82), respectively. CONCLUSIONS: We identified an additional 28.5% of candidates bridged with ECMO prior to transplant using new data. This study of the newly identified full cohort of ECMO candidates demonstrates higher utilization of ECMO as well as an underestimation of waitlist mortality risk factors that should inform strategies to provide timely access to transplants for this population.
引用
- Lehr CJ, Schold JD, Arrigain S, et al. New OPTN/UNOS data demonstrates higher than previously reported waitlist mortality for lung transplant candidates supported with ECMO. J Heart Lung Transplant. 2023. PMID: 37150472. doi:10.1016/j.healun.2023.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。